#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14498	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2130	677.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1685	1685	T	814	T	745	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14498	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2130	677.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	864	C,G	812,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26926	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3656	735.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1677	1677	A	888	A	825	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26926	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3656	735.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2311	2311	C	861	C	802	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26926	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3656	735.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2385	2385	A	891	A	831	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26926	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3656	735.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2937	2937	C	825	C,T,A	773,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	20	blaTEM	861	314	100.0	blaTEM.l6.c4.ctg.1	314	2.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	20	blaTEM	861	162	100.0	blaTEM.l6.c4.ctg.2	211	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	419	421	CAG	150;153;152	C;A;G	138;143;142	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	D29N	NONSYN	85	87	GAT	485	487	AAT	203;199;200	A;A;T	182;186;185	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	P68L	NONSYN	202	204	CCG	602	604	TTG	185;183;185	T;T;G	166;168;173	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	614	616	TAT	177;175;174	T;A;T	163;164;164	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	P74S	NONSYN	220	222	CCG	620	622	TCG	182;182;184	T;C;G	166;166;163	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	P75del	DEL	223	223	C	623	623	C	185	C,T	164,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	E76D	NONSYN	226	228	GAA	624	626	CTG	187;189;187	C;T;G	170;170;169	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	A90V	NONSYN	268	270	GCG	665	667	GTG	159;160;162	G;T;G	143;136;142	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	A91V	NONSYN	271	273	GCG	668	670	GTT	161;165;165	G;T;T	144;145;147	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	V97I	NONSYN	289	291	GTC	686	688	ATC	167;164;165	A;T;C	151;148;148	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	R136C	NONSYN	406	408	CGC	803	805	TGT	179;178;182	T;G;T	166;167;165	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	R148Q	NONSYN	442	444	CGG	839	841	CAG	186;183;182	C;A;G	169;167;167	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	T153N	NONSYN	457	459	ACC	854	856	AAC	182;184;186	A;A;C	170;172;174	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	D156I	NONSYN	466	468	GAC	863	865	ATT	186;188;189	A;T;T	172;172;174	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	T173A	NONSYN	517	519	ACA	914	916	GCG	195;196;193	G;C;G,A	179;181;178,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	E176A	NONSYN	526	528	GAA	923	925	GCG	196;195;195	G;C;G	182;183;183	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	T177E	NONSYN	529	531	ACC	926	928	GAA	196;196;196	G;A;A	184;185;182	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	V179I	NONSYN	535	537	GTC	932	934	ATC	202;203;199	A;T;C,T	188;187;185,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	T189I	NONSYN	565	567	ACG	962	964	ATA	204;205;203	A;T;A	194;191;187	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	1984	folP	855	855	91.19	folP.l15.c4.ctg.1	1652	119.9	0	.	p	.	0	D191fs	FSHIFT	571	571	G	968	968	G	199	G	185	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6006	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3315	180.7	1	SNP	p	S91F	1	.	.	271	273	TTC	566	568	TTC	227;227;226	T;T;C	214;212;211	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6006	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3315	180.7	1	SNP	p	D95G	1	.	.	283	285	GGC	578	580	GGC	227;226;221	G;G;C	212;211;205	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6006	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3315	180.7	1	SNP	p	G95N	0	.	.	283	285	GGC	578	580	GGC	227;226;221	G;G;C	212;211;205	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1714	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1370	124.9	1	SNP	p	G45D	0	.	.	133	135	GGC	486	488	GGC	221;221;217	G;G;C	200;201;198	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	838	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1093	76.6	0	.	n	.	0	A197.	DEL	197	197	A	579	579	A	195	A	181	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5142	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2943	174.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1443	1445	GTC	212;215;213	G;T;C	200;203;202	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5142	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2943	174.0	1	SNP	p	D86N	0	.	.	256	258	GAC	549	551	GAC	206;203;201	G;A;C	195;192;194	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5142	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2943	174.0	1	SNP	p	R87I	0	.	.	259	261	CGT	552	554	CGT	203;202;205	C,A;G;T	196,1;191;194	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5142	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2943	174.0	1	SNP	p	R87W	0	.	.	259	261	CGT	552	554	CGT	203;202;205	C,A;G;T	196,1;191;194	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5142	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2943	174.0	1	SNP	p	S87R	1	.	.	259	261	CGT	552	554	CGT	203;202;205	C,A;G;T	196,1;191;194	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5142	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2943	174.0	1	SNP	p	S88P	0	.	.	262	264	TCC	555	557	TCC	203;204;208	T;C;C	194;195;198	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4612	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2682	171.3	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1333	1335	TGC	220;225;221	T,C;G;C	202,1;207;204	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4612	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2682	171.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1543	1545	GGC	225;224;222	G;G,A;C	208;206,1;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1188	1190	GCA	221;220;222	G,A;C;A	202,1;201;206	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1191	1193	ATC	227;227;233	A;T,A;C	208;207,1;213	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1203	1205	GTG	239;240;242	G;T;G	219;221;222	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1203	1205	GTG	239;240;242	G;T;G	219;221;222	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1707	1709	ACC	212;211;212	A;C;C	192;193;196	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1761	1763	GCG	175;175;172	G;C;G	153;135;138	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1761	1763	GCG	175;175;172	G;C;G	153;135;138	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1884	1886	GGC	172;169;169	G;G;C	156;155;153	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1893	1895	GGC	168;168;169	G;G;C	153;150;153	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2269	182.2	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1911	1913	TCG	171;172;170	T,G,C;C;G	113,8,1;136;140	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5980	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3033	196.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1603	1605	CCG	233;234;241	C;C;G	201;211;210	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2362	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1646	142.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	501	501	C	182	C	169	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	407	409	GAA	241;241;239	G;A;A	216;218;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	695	697	GAT	225;224;223	G;A;T	207;204;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	818	820	TCA	209;208;209	T;C;A	195;195;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	947	949	GTC	245;245;246	G;T;C	227;225;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1169	1171	ACT	220;221;221	A;C;T	209;211;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1277	1279	GCA	208;211;213	G;C;A	197;196;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	1	SNP	p	G120K	1	.	.	358	360	AAG	653	655	AAG	219;217;218	A;A;G	202;200;199	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	1	SNP	p	A121D	1	.	.	361	363	GAC	656	658	GAC	218;218;221	G;A;C	200;199;202	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2656	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1487	177.2	1	SNP	p	D121N	0	.	.	361	363	GAC	656	658	GAC	218;218;221	G;A;C	200;199;202	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9922	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4976	198.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2065	2067	AAT	205;205;205	A;A;T	196;194;193	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1136	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1044	108.3	1	SNP	p	V57M	1	.	.	169	171	ATG	472	474	ATG	251;253;249	A;T;G	238;240;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
